echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Sci Rep: Worthy of being an "angel in cancer"?

    Sci Rep: Worthy of being an "angel in cancer"?

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Primary liver cancer (PLC) is the fourth leading cause of cancer-related death worldwide


    The number of long-term cancer survivors continues to rise as cancer treatments evolve and early diagnosis rates increase


    This study used data from the Surveillance, Epidemiology and End Results (SEER) database to analyze the survival of PLC patients with and without thyroid cancer to determine whether a history of thyroid cancer affects the survival of PLC patients


    Eligible PLC patients were selected from data from the Surveillance, Epidemiology and End Results (SEER) database for the period 2004-2016


    A total of 142 PLC patients with a history of thyroid cancer and 1420 PLC patients without previous thyroid cancer were included in the study


    The median survival time of PLC patients was 11.


    A subgroup analysis stratified by sex showed a similar relationship between women and PLC: women with previous thyroid cancer had a lower risk of death from PLC (HR = 0.


    Figure 3a depicts the cumulative incidence of PLC-specific death between female PLC patients with and without previous thyroid cancer


    Overall, prior thyroid cancer reduces the risk of PLC-specific death in PLC patients, especially women


    Original source:

    Liu, H.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.